ANI Pharmaceuticals | ANIP - Ordinary Share Capital


ANI Pharmaceuticals reported $22.49M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Omeros USD 611K 17K Dec/2023
Perrigo USD 137.6M 0 Dec/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025